Bernadette Jäger

558 total citations
32 papers, 423 citations indexed

About

Bernadette Jäger is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bernadette Jäger has authored 32 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 14 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bernadette Jäger's work include Cancer Cells and Metastasis (16 papers), Breast Cancer Treatment Studies (7 papers) and HER2/EGFR in Cancer Research (6 papers). Bernadette Jäger is often cited by papers focused on Cancer Cells and Metastasis (16 papers), Breast Cancer Treatment Studies (7 papers) and HER2/EGFR in Cancer Research (6 papers). Bernadette Jäger collaborates with scholars based in Germany, United States and France. Bernadette Jäger's co-authors include Brigitte Rack, Wolfgang Janni, Klaus Pantel, Heidi Schwarzenbach, Tanja Fehm, Thomas W. P. Friedl, F Meier-Stiegen, Udo Jeschke, Eugen Ruckhäberle and M. Suckfüll and has published in prestigious journals such as Applied Physics Letters, Cancer Research and International Journal of Cancer.

In The Last Decade

Bernadette Jäger

31 papers receiving 408 citations

Peers

Countries citing papers authored by Bernadette Jäger

Since Specialization

Citations

This map shows the geographic impact of Bernadette Jäger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernadette Jäger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernadette Jäger more than expected).

Fields of papers citing papers by Bernadette Jäger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernadette Jäger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernadette Jäger. The network helps show where Bernadette Jäger may publish in the future.

Co-authorship network of co-authors of Bernadette Jäger

This figure shows the co-authorship network connecting the top 25 collaborators of Bernadette Jäger. A scholar is included among the top collaborators of Bernadette Jäger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernadette Jäger. Bernadette Jäger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Psychosocial outcomes of risk-adapted prevention for prostate cancer predisposition: study protocol for a longitudinal observational mixed-methods study 2025 ·BMJ Open ·(unknown), Petra Seibold, (unknown), Günter Niegisch, Gerald Antoch, Matthias Boschheidgen, Ulrike Dinger, Tanja Fehm, Bernadette Jäger, Silke Redler, (unknown), Ralf B. Schäfer, (unknown), André Karger	1
2	Circulating Tumor DNA in Early and Metastatic Breast Cance—Current Role and What Is Coming Next 2024 ·Cancers ·(unknown), Andreas D. Hartkopf, Maggie Banys‐Paluchowski, Natalia Krawczyk, Tanja Fehm, Bernadette Jäger	3
3	Impact of surgical variables on residual glandular tissue in risk-reducing mastectomies: Results of a retrospective monocentric study from a center of the German consortium for hereditary breast and ovarian cancer 2023 ·European Journal of Surgical Oncology ·Svjetlana Mohrmann, (unknown), Bernadette Jäger, Jürgen Hoffmann, Carolin Nestle-Krämling, (unknown), (unknown), Lino M. Sawicki, Nils Martin Bruckmann, (unknown), Janna Morawitz, Gerald Antoch, Tanja Fehm, Julian Kirchner, Frederic Dietzel	1
4	Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program 2021 ·ESMO Open ·Volkmar Müller, Maggie Banys‐Paluchowski, Thomas W. P. Friedl, Peter A. Fasching, Andreas Schneeweiß, Andreas D. Hartkopf, D. Wallwiener, Brigitte Rack, F Meier-Stiegen, Jens Huober, Matthias Rübner, Oliver Hoffmann, (unknown), Wolfgang Janni, Pauline Wimberger, Bernadette Jäger, Klaus Pantel, Sabine Riethdorf, Nadia Harbeck, Tanja Fehm	45
5	Use of Granulocyte-colony Stimulating Factor During Chemotherapy and Its Association With CA27.29 and Circulating Tumor Cells—Results From the SUCCESS A Trial 2018 ·Clinical Breast Cancer ·Philip Hepp, Peter A. Fasching, Matthias W. Beckmann, Tanja Fehm, (unknown), Carsten Hagenbeck, Bernadette Jäger, Peter Widschwendter, Nikolaus de Gregorio, Fabienne Schochter, Sven Mahner, Nadia Harbeck, Tobias Weissenbacher, (unknown), Thomas W. P. Friedl, Wolfgang Janni, Brigitte Rack	1
6	Abstract P2-05-02: Active surveillance with a combination of tumor marker CA27.29 and detection of circulating tumor cells two year after primary diagnosis strongly predicts subsequent prognosis 2017 ·Cancer Research ·W Janni, Brigitte Rack, Lothar Häberle, Thomas W. P. Friedl, Hans Tesch, Ralf Lorenz, Bernadette Jäger, Tanja Fehm, Volkmar Müller, Andreas Schneeweiß, W. Lichtenegger, Jens‐Uwe Blohmer, MW Beckmann, Christoph Scholz, Klaus Pantel, Elisabeth Trapp, PA Fasching	1
7	Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial 2016 ·Geburtshilfe und Frauenheilkunde ·(unknown), Brigitte Rack, H. Sommer, (unknown), (unknown), Wolfgang Janni, Andreas Schneeweiß, Mahdi Rezai, Ralf Lorenz, Bernadette Jäger, (unknown), Lothar Häberle, (unknown), Thomas W. P. Friedl, (unknown), Christoph Scholz	7
8	Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer – The SUCCESS Trial 2016 ·Anticancer Research ·Philip Hepp, Ulrich Andergassen, Bernadette Jäger, Elisabeth Trapp, Marianna Alunni‐Fabbroni, Thomas W. P. Friedl, (unknown), Ralf Lorenz, Peter A. Fasching, Andreas Schneeweiß, Tanja Fehm, Wolfgang Janni, Brigitte Rack	12
9	Detection of circulating tumor cells during long-term follow-up of high-risk breast cancer patients indicates poor prognosis – results of the adjuvant SUCCESS A trial 2016 ·Geburtshilfe und Frauenheilkunde ·Elisabeth Trapp, Brigitte Rack, (unknown), Lothar Häberle, Hans Tesch, R. Lorenz, (unknown), Marie Tzschaschel, Marianna Alunni‐Fabbroni, (unknown), J. Schmucker-Von Koch, Bernadette Jäger, Volkmar Müller, Sven Mahner, Tanja Fehm, Andreas Schneeweiß, MW Beckmann, W. Lichtenegger, Christian W. Scholz, W Janni	1
10	Determination of Interleukin-4, -5, -6, -8 and -13 in Serum of Patients with Breast Cancer Before Treatment and its Correlation to Circulating Tumor Cells. 2016 ·PubMed ·Alexander König, Theresa� Vilsmaier, Brigitte Rack, Klaus Friese, Wolfgang Janni, Udo Jeschke, Ulrich Andergassen, Elisabeth Trapp, Julia Jückstöck, Bernadette Jäger, Marianna Alunni‐Fabbroni, Thomas W. P. Friedl, Tobias Weissenbacher, (unknown)	30
11	Estrogen Receptor and HER2 Status on Disseminated Tumor Cells and Primary Tumor in Patients with Early Breast Cancer 2015 ·Translational Oncology ·Bernadette Jäger, (unknown), (unknown), (unknown), J Jueckstock, Ulrich Andergassen, Julia Neugebauer, Aurelia Pestka, Thomas W. P. Friedl, Udo Jeschke, Wolfgang Janni, Sophie Doisneau-Sixou, Brigitte Rack	13
12	Abstract P4-11-21: Prevalence of circulating tumor cells (CTCs) after five years of zoledronate treatment in the adjuvant SUCCESS-A study 2015 ·Cancer Research ·Brigitte Rack, Peter A. Fasching, Lothar Häberle, Thomas W. P. Friedl, Mahdi Rezai, J. Hilfrich, Hans Tesch, Georg Heinrich, Helmut Forstbauer, Julia Neugebauer, Elisabeth Trapp, Susanne Albrecht, Bernadette Jäger, Tanja Fehm, Volkmar Müller, Andreas Schneeweiß, Klaus Friese, W. Lichtenegger, Matthias W. Beckmann, Wolfgang Janni	1
13	520-d Isolation and confinement simulating a flight to Mars reveals heightened immune responses and alterations of leukocyte phenotype 2014 ·Brain Behavior and Immunity ·Buqing Yi, М. П. Рыкова, Matthias Feuerecker, Bernadette Jäger, (unknown), Mathias Basner, (unknown), (unknown), Inès Kaufmann, Claudia Strewe, И. А. Ничипорук, Galina Vassilieva, (unknown), Sarah Baatout, Gustav Schelling, M. Thiel, David F. Dinges, Б. В. Моруков, Alexander Choukèr	33
14	Knochenmetastasen 2013 ·Der Gynäkologe ·Bernadette Jäger, (unknown), (unknown), W Janni	0
15	Breast Cancer: State of the Art and New Findings 2012 ·Geburtshilfe und Frauenheilkunde ·(unknown), Christoph Scholz, Bernadette Jäger, Carsten Hagenbeck, Brigitte Rack, Wolfgang Janni	12
16	Heterogeneity of ERα and ErbB2 Status in Cell Lines and Circulating Tumor Cells of Metastatic Breast Cancer Patients 2012 ·Translational Oncology ·(unknown), Brigitte Rack, Christina Kühn, Simone Hofmann, (unknown), Bernadette Jäger, Udo Jeschke, Sophie Doisneau-Sixou	15
17	OT1-02-06: DETECT III – A Multicenter, Randomized, Phase III Study To Compare Standard Therapy Alone Versus Standard Therapy Plus Lapatinib in Patients with Initially HER2−Negative Metastatic Breast Cancer and HER2−Positive Circulating Tumor Cells. 2011 ·Cancer Research ·(unknown), Wolfgang Janni, (unknown), Bernadette Jäger, (unknown), Volkmar Müller, Andreas Schneeweiß, Klaus Pantel, (unknown), Tanja Fehm	1
18	Medikamentöse und psychologische Therapien bei chronischem subjektivem Tinnitus 2000 ·HNO ·(unknown), Bernadette Jäger, R. Heermann, Friedhelm Lamprecht	16
19	Heparin-induced extracorporal low-density-lipoprotein precipitation (H. E. L. P.) to improve the recovery of hearing in patients with sudden idiopathic hearing loss 2000 ·European Archives of Oto-Rhino-Laryngology ·M. Suckfüll, C. Wimmer, Bernadette Jäger, K. Schorn, Joachim Thiery	19
20	Local hyperthermia, hyperfractionated radiation, and cisplatin in preirradiated recurrent lymph node metastases of recurrent head and neck cancer 1997 ·International Journal of Oncology ·Thomas Feyerabend, Richard A. Steeves, Bernadette Jäger, Günther Wiedemann, (unknown), Elihu D. Richter, Dörthe M. Katschinski, H. Ian Robins	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact